Antimicrobial Resistance Following Azithromycin Mass Drug Administration: Potential Surveillance Strategies to Assess Public Health Impact.

Mack, Ines; Sharland, Mike; Berkley, James A; Klein, Nigel; Malhotra-Kumar, Surbhi; Bielicki, Julia

Mack, Ines; Sharland, Mike; Berkley, James A; Klein, Nigel; Malhotra-Kumar, Surbhi; Bielicki, Julia.

Afiliación

Mack I; Pediatric Infectious Diseases, University Children's Hospital Basel, Basel, Switzerland.
Sharland M; Pediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Berkley JA; Center for Tropical Medicine and Global Health, University of Oxford, United Kingdom.
Klein N; KEMRI/Wellcome Trust Research Program, Kilifi, Kenya.
Malhotra-Kumar S; UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Bielicki J; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Antwerp, Belgium.

Clin Infect Dis ; 70(7): 1501-1508, 2020 03 17.

Article en En | MEDLINE | ID: mdl-31633161

Asunto(s)

Azitromicina; Tracoma; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Azitromicina/farmacología; Azitromicina/uso terapéutico; Niño; Farmacorresistencia Bacteriana; Humanos; Lactante; Administración Masiva de Medicamentos; Salud Pública; Tracoma/tratamiento farmacológico

Palabras clave

antimicrobial resistance; azithromycin; macrolide; mass drug administration; surveillance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tracoma / Azitromicina Tipo de estudio: Clinical_trials / Screening_studies Límite: Child / Humans / Infant Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google